Harbor Capital Advisors, Inc. Logic Bio Therapeutics, Inc. Transaction History

Harbor Capital Advisors, Inc.

  • $2.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$0.35 - $0.74 $2,996 - $6,335
8,561 Added 3.78%
235,292 $85,000
Q1 2022

Apr 28, 2022
SELL
$0.61 - $2.49 $34,066 - $139,059
-55,847 Reduced 19.76%
226,731 $154,000
Q4 2021

Feb 04, 2022
BUY
$2.2 - $4.53 $621,671 - $1.28 Million
282,578 New
282,578 $653,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email